Evidence map›Paper›PMID 29802279›Full record

ArticleScientific reports2018

An in vitro method to keep human aortic tissue sections functionally and structurally intact.

Jorn P Meekel, Menno E Groeneveld, Natalija Bogunovic, Niels Keekstra, René J P Musters, Behrouz Zandieh-Doulabi, Gerard Pals, Dimitra Micha, Hans W M Niessen, Arno M Wiersema and 5 more

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Non-Coding RNA-Targeted Therapy: A State-of-the-Art Review.International journal of molecular sciences · 2024
    Review
  4. Article
  5. MicroRNAs as therapeutic targets in cardiovascular disease.The Journal of clinical investigation · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Jorn P MeekelVU University Medical Center, Department of Vascular Surgery, Amsterdam, The Netherlands.
Menno E GroeneveldVU University Medical Center, Department of Vascular Surgery, Amsterdam, The Netherlands.
Natalija BogunovicVU University Medical Center, Department of Vascular Surgery, Amsterdam, The Netherlands.
Niels KeekstraVU University Medical Center, Department of Vascular Surgery, Amsterdam, The Netherlands.
René J P MustersVU University Medical Center, Amsterdam Cardiovascular Sciences, Department of Physiology, Amsterdam, The Netherlands.
Behrouz Zandieh-DoulabiVU University Medical Center, Department of Clinical Genetics, Amsterdam, The Netherlands.ORCID 0000-0002-0290-3241
Gerard PalsVU University Medical Center, Department of Clinical Genetics, Amsterdam, The Netherlands.
Dimitra MichaVU University Medical Center, Department of Clinical Genetics, Amsterdam, The Netherlands.
Hans W M NiessenVU University Medical Center, Department of Pathology, Amsterdam, The Netherlands.
Arno M WiersemaWestfriesgasthuis, Department of Vascular Surgery, Hoorn, The Netherlands.
Jur K KievitWestfriesgasthuis, Department of Vascular Surgery, Hoorn, The Netherlands.
Arjan W J HoksbergenVU University Medical Center, Department of Vascular Surgery, Amsterdam, The Netherlands.
Willem WisselinkVU University Medical Center, Department of Vascular Surgery, Amsterdam, The Netherlands.
Jan D BlankensteijnVU University Medical Center, Department of Vascular Surgery, Amsterdam, The Netherlands.
Kak K YeungVU University Medical Center, Department of Vascular Surgery, Amsterdam, The Netherlands. k.yeung@vumc.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pathophysiology of aortic aneurysms (AA) is far from being understood. One reason for this lack of understanding is basic research being constrained to fixated cells or isolated cell cultures, by which cell-to-cell and cell-to-matrix communications are missed. We present a new, in vitro method for extended preservation of aortic wall sections to study pathophysiological processes. Intraoperatively harvested, live aortic specimens were cut into 150 μm sections and cultured. Viability was quantified up to 92 days using immunofluorescence. Cell types were characterized using immunostaining. After 14 days, individual cells of enzymatically digested tissues were examined for cell type and viability. Analysis of AA sections (N = 8) showed a viability of 40% at 7 days and smooth muscle cells, leukocytes, and macrophages were observed. Protocol optimization (N = 4) showed higher stable viability at day 62 and proliferation of new cells at day 92. Digested tissues showed different cell types and a viability up to 75% at day 14. Aortic tissue viability can be preserved until at least 62 days after harvesting. Cultured tissues can be digested into viable single cells for additional techniques. Present protocol provides an appropriate ex vivo setting to discover and study pathways and mechanisms in cultured human aneurysmal aortic tissue.

Indexed as

AortaAortic AneurysmGene Expression RegulationHumansTissue Survival

Identifiers

PMID29802279
PMCPMC5970251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.